Lung Disease News |
GSK Expands Its COPD And Asthma Portfolio Across The US
Lung Disease News shutterstock_64961809 GlaxoSmithKline (GSK) recently announced that two of its latest approved products are now available in retail pharmacies across the United States to treat both chronic obstructive pulmonary disease (COPD) and asthma. In the United … |
View full post on asthma – Google News